Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Summers (Cambridge (Cambridgeshire), United Kingdom). Inhaled antibodies: targeting tumour necrosis factor receptor 1 and thymic stromal lymphopoietin. International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments

Member's Comments

No comment yet.

Related content which might interest you: IL-4Ra signaling is required for thymic stromal lymphopoietin (TSLP)-induced type 2 airway inflammation Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021 FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells Source: Eur Respir J 2009; 33: 425-435 Year: 2009 Mast cell-derived tumour necrosis factor is essential for allergic airway disease Source: Eur Respir J 2008; 31: 773-782 Year: 2008 Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma Source: Annual Congress 2004 - Inflammation and remodelling in human lungs Year: 2004 Thymic stromal lymphopoietin promotes asthmatic airway remodeling in human lung fibroblast cells through stat3 signaling pathway Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin Source: International Congress 2018 – Roles of innate lymphoid cells in asthma Year: 2018 Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma Source: Eur Respir J 2003; 21: 804-809 Year: 2003 Blockade of thymic stromal lymphopoietin receptor (TSLPR) reduces atopic inflammation in a cynomolgus monkey model of asthma Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 Peripheral blood TSLP (thymic stromal lymphopoietin) in children as a biomarker? Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021 Vanadium pentoxide induced epithelial innate cytokines IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) through activating MAPK pathway Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 YS3: Thymic stromal lymphopoietin is a central regulator of anti-viral CD8+ T cell responses Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 Levels of plasma tumour necrosis factor and soluble tumour necrosis factor receptor in patients with COPD and its relation to glucocorticoid receptor levels Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Current evidence of epidermal barrier dysfunction and thymic stromal lymphopoietin in the atopic march Source: Eur Respir Rev 2014; 23: 292-298 Year: 2014 Down regulation of stromal cell-derived factor 1 (SDF-1/CXCL12) in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Analysing disease-specific variants of thymic stromal lymphopoietin (TSLP) in asthma Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Interferon gamma decreases interleukin-8 production and neurokinin-1 receptor expression in lung alveolar epithelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 80s Year: 2001 Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Serum thymic stromal lymphopoietin level depends on allergic profile in pediatric asthma Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies Year: 2021